Michael Schmertzler

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.

3 years · Since 2023
1 month · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 14, 2026 PTC Therapeutics Inc. Open-market sale −2,118 $59.52 $126,063
Oct 14, 2026 PTC Therapeutics Inc. Open-market sale −382 $60.14 $22,973
Oct 7, 2026 PTC Therapeutics Inc. Open-market sale −2,447 $63.38 $155,091
Oct 7, 2026 PTC Therapeutics Inc. Open-market sale −53 $63.95 $3,389
Sep 17, 2026 PTC Therapeutics Inc. Open-market sale −9,624 $67.83 $652,796
Sep 17, 2026 PTC Therapeutics Inc. Open-market sale −376 $68.45 $25,737
Sep 16, 2026 Hamilton Lane Incorporated Grant or award +977 — —
Sep 16, 2026 PTC Therapeutics Inc. Open-market sale −2,994 $66.58 $199,341
Sep 16, 2026 PTC Therapeutics Inc. Open-market sale −7,006 $67.35 $471,854
Sep 10, 2026 PTC Therapeutics Inc. Open-market sale −10,000 $67.34 $673,400
Sep 9, 2026 PTC Therapeutics Inc. Open-market sale −9,428 $67.79 $639,124
Sep 9, 2026 PTC Therapeutics Inc. Open-market sale −572 $68.67 $39,279
Aug 27, 2026 PTC Therapeutics Inc. Open-market sale −11,890 $71.55 $850,730
Aug 27, 2026 PTC Therapeutics Inc. Open-market sale −610 $72.22 $44,054
Aug 26, 2026 PTC Therapeutics Inc. Open-market sale −6,874 $72.74 $500,015

Questions about Michael Schmertzler

What boards is Michael Schmertzler on?

Michael Schmertzler sits on the boards of Hamilton Lane Incorporated and PTC Therapeutics Inc.

How long has Michael Schmertzler served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.